Association between C-reactive protein level and echocardiography assessed left ventricular function in first

Yacov Shacham1, Yan Topilsky1, Eran Leshem-Rubinow1

  • 1Department of Cardiology, Tel-Aviv Sourasky Medical Center affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Journal of Cardiology
|December 5, 2013
PubMed

Insights

Elevated C-reactive protein (CRP) levels after ST-segment elevation myocardial infarction (STEMI) correlate with impaired left ventricular diastolic function. Higher CRP indicates worse diastolic dysfunction and elevated filling pressures in STEMI patients treated with primary percutaneous coronary intervention.

Area of Science:

  • Cardiology
  • Biomarkers
  • Echocardiography

Background:

  • Elevated C-reactive protein (CRP) is linked to adverse outcomes in acute myocardial infarction (AMI).
  • CRP's association with left ventricular (LV) systolic function in AMI is known, but its relation to early diastolic function is unclear.

Purpose of the Study:

  • To investigate the association between admission C-reactive protein (CRP) levels and early left ventricular (LV) diastolic function in patients with ST-segment elevation myocardial infarction (STEMI).

Main Methods:

  • Retrospective study of 173 patients (<75 years) with first STEMI treated with primary percutaneous coronary intervention (PPCI).
  • CRP levels measured within 6 hours of admission; echocardiography performed within 3 days.
  • Patients stratified by CRP tertiles (<2.6 mg/L, 2.6-7.9 mg/L, >7.9 mg/L).

Main Results:

  • Higher CRP tertiles showed significantly increased mitral inflow E wave velocity and E/average e' ratio.
  • Elevated CRP levels were associated with higher systolic pulmonary artery pressure and more advanced diastolic dysfunction (p=0.04).
  • Admission CRP level independently predicted the average E/e' ratio in multivariate analysis.

Conclusions:

  • Admission CRP levels correlate with echocardiographic markers of elevated LV filling pressure in STEMI patients undergoing PPCI.
  • Higher CRP levels indicate more significant diastolic dysfunction and elevated filling pressures.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
943
Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
1.0K